Comparison of the effect of Aspirin at doses of 80 and 160 mg on the prevention of preeclampsia in women with abnormal Doppler ultrasound of the uterine artery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210804052071N1

Enrollment

300

Registered

2022-03-03

Start date

2022-01-21

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia. Pre-eclampsia

Interventions

Intervention 1: Intervention group: Pregnant women who will take aspirin 80 mg. Aspirin 80 mg from Galenus Pharmaceutical Company will be taken orally once a day from the time of enrollment until the

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant mothers at 18 to 22 weeks with impaired uterine artery Doppler Being single

Exclusion criteria

Exclusion criteria: Premature birth for reasons other than blood pressure The mother's unwillingness to continue cooperating Not taking the right medication

Design outcomes

Primary

Measure	Time frame
Preeclampsia. Timepoint: During pregnancy up to 40 days after delivery. Method of measurement: Mercury sphygmomanometer, urine test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMitra Eftekhari Yazdi

Sabzevar University of Medical Sciences

m_eftekhari1144@yahoo.com+98 51 4423 8100

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026